Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763

Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies

Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602

The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>

Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104

QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1

GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644

HPV Screening for Cervical Cancer in Rural India

Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278

Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

Mayrand, M., Duarte‐Franco, E., Rodrigues, I., Walter, S. D., Hanley, J. A., Ferenczy, A. S., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,106

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Ronco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 955

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Nauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Johansson, B., Forslund, O., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073204 · Cited by 797

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document

Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762

Cervical Cancer Incidence Among US Women, 2001-2019

Shahmoradi, Z., Damgacioglu, H., Clarke, M. A., Wentzensen, N., Montealegre, J. R., Sonawane, K., & Deshmukh, A. A. (2022) · JAMA · doi:10.1001/jama.2022.17806 · Cited by 41

A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types

Huber, B., Schellenbacher, C., Jindra, C., Fink, D., Shafti‐Keramat, S., & Kirnbauer, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120152 · Cited by 41

Clinical application of DNA ploidy to cervical cancer screening: A review

Garner, D. M. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i5.931 · Cited by 41

A Suggested Approach to Simplify and Improve Cervical Screening in the United States

SCHIFFMAN, M. H., & Wentzensen, N. (2015) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000170 · Cited by 43

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening

Ejegod, D. M., Bottari, F., Pedersen, H., Sandri, M. T., & Bonde, J. H. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00508-16 · Cited by 41

MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study

Becker, A. S., Ghafoor, S., Marcon, M., Perucho, J. A. U., Wurnig, M. C., Wagner, M. W., Khong, P., Lee, E. Y. P., & Boss, A. (2017) · Acta Radiologica Open · doi:10.1177/2058460117729574 · Cited by 41

MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression

Zhu, Y., Han, Y., Tian, T., Su, P., Guan, J., Chen, J., & Cao, Y.-G. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.01.001 · Cited by 41

Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany

Horn, J., Denecke, A., Luyten, A., Rothe, B., Reinecke‐Lüthge, A., Mikolajczyk, R., & Petry, K. U. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0453-2 · Cited by 41

Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study

Megersa, B. S., Bussmann, H., Bärnighausen, T., Muche, A. A., Alemu, K., & Deckert, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243036 · Cited by 44

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening

Luo, H., Belinson, J. L., Du, H., Liu, Z., Zhang, L., Wang, C., Qu, X., Pretorius, R. G., & Wu, R. (2016) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000277 · Cited by 40

HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows

Huijsmans, C. J. J., Geurts-Giele, W. R. R., Leeijen, C., Hazenberg, H. L. C. M., van Beek, J., Wild, C., van der Linden, J. C., & van den Brule, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2961-2 · Cited by 40

Epidemiology of Humanpapilloma virus infection among women in Fujian, China

Wu, C., Zhu, X., Kang, Y., Cao, Y., Lu, P., Zhou, W., Zhou, H., Zhang, Y., & Song, Y. (2017) · BMC Public Health · doi:10.1186/s12889-017-4651-7 · Cited by 40

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening

Ejegod, D. M., Pedersen, H., Alzua, G. P., Pedersen, C., & Bonde, J. H. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2018.04.005 · Cited by 40

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Iftner, T., Neis, K.-J., Castañón, A., Landy, R., Holz, B., Woll-Herrmann, A., Iftner, A., Staebler, A., Wallwiener, D. R., von Weyhern, C. H., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01177-18 · Cited by 40

High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil

Levi, J. E., Martins, T. R., Longatto‐Filho, A., Cohen, D. D., Cury, L., Fuza, L. M., Villa, L. L., & Eluf‐Neto, J. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0076 · Cited by 40

Clinical performance of the Food and Drug Administration–Approved high‐risk HPV test for the detection of high‐grade cervicovaginal lesions

Zhou, H. S., Mody, R. R., Luna, E., Armylagos, D., Xu, J., Schwartz, M. R., Mody, D. R., & Ge, Y. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21687 · Cited by 39

Evaluation of Six Methylation Markers Derived from Genome-Wide Screens for Detection of Cervical Precancer and Cancer

Dick, S., Verhoef, L., Strooper, L. M. A. D., Ciocănea‐Teodorescu, I., Wisman, G. B. A., Meijer, C. J. L. M., Bleeker, M. C. G., Steenbergen, R. D. M., & Heideman, D. A. M. (2020) · Epigenomics · doi:10.2217/epi-2019-0331 · Cited by 39

Interpretation of p16INK4a/Ki‐67 dual immunostaining for the triage of human papillomavirus‐positive women by experts and nonexperts in cervical cytology

Allìa, E., Ronco, G., Coccia, A., Luparia, P., Macrì, L., Fiorito, C., Maletta, F., Deambrogio, C., Tùnesi, S., Marco, L. D., et al. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21511 · Cited by 41

Innovative approaches to cervical cancer screening in low- and middle-income countries

Toliman, P. J., Kaldor, J. M., Tabrizi, S. N., & Vallely, A. J. (2018) · Climacteric · doi:10.1080/13697137.2018.1439917 · Cited by 39

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution

Kang, M., Ha, S. Y., Cho, H. Y., Chung, D. H., Kim, N. R., An, J., Lee, S.-H., Seok, J. Y., & Jeong, J. (2020) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.11.29 · Cited by 39

Diagnostic accuracy of cervical cancer screening and screening–triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study

Kelly, H. A., Chikandiwa, A. T., Sawadogo, B., Gilham, C., Michelow, P. M., Lompo, O., Omar, T., Zan, S., Magooa, P., Segondy, M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003528 · Cited by 40

Human papillomavirus and cervical cancer

Okunade, K. S. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1674261 · Cited by 39

Human Papillomavirus and Cervical Cancer

Okunade, K. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81581 · Cited by 39

Implementation of HPV ‐testing for cervical cancer screening in programmatic contexts: The J ujuy demonstration project in A rgentina

Arrossi, S., Thouyaret, L., Laudi, R., Marín, O., Ramírez, J., Paolino, M., Herrero, R., & Campanera, A. (2015) · International Journal of Cancer · doi:10.1002/ijc.29530 · Cited by 42

Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older—A national cohort study

Hammer, A., Soegaard, V., Maimburg, R. D., & Blaakær, J. (2019) · Cancer Medicine · doi:10.1002/cam4.1926 · Cited by 40

The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population

Khoo, S. P., Lim, W. T., Rajasuriar, R., Nasir, N. H., Gravitt, P. E., & Woo, Y. L. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0280 · Cited by 38

Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries (Review)

Bogdanova, A. A., Andrawos, C., & Constantinou, C. (2022) · Oncology Letters · doi:10.3892/ol.2022.13233 · Cited by 42

Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control

Castle, P. E. (2024) · Viruses · doi:10.3390/v16091357 · Cited by 40

Cervical cancer screening in Germany: group-specific participation rates in the state of Niedersachsen (Lower Saxony). A study with health insurance data

Geyer, S., Jaunzeme, J., & Hillemanns, P. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3421-3 · Cited by 38

Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland

Duke, P. S., Godwin, M. S., Ratnam, S., Dawson, L. M., Fontaine, D., Lear, A., Traverso-Yépez, M. A., Graham, W., Ravalia, M., Mugford, G., et al. (2015) · BMC Women s Health · doi:10.1186/s12905-015-0206-1 · Cited by 39

A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer

Cheng, F., Wen, Z., Feng, X., Wang, X., & Chen, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118489 · Cited by 38

Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls

Cafforio, P., Palmirotta, R., Lovero, D., Cicinelli, E., Cormio, G., Silvestris, E., Porta, C., & D’Oronzo, S. (2021) · Cancers · doi:10.3390/cancers13163968 · Cited by 38

Generation of affibody molecules specific for HPV16 E7 recognition

Xue, X., Wang, B., Du, W., Zhang, C., Song, Y., Cai, Y., Cen, D., Wang, L., Xiong, Y., Jiang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12174 · Cited by 38

Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy

Martinelli, M., Giubbi, C., Meo, M. L. D., Perdoni, F., Musumeci, R., Leone, B. E., Fruscio, R., Landoni, F., & Cocuzza, C. E. (2023) · Viruses · doi:10.3390/v15091889 · Cited by 41

Human Papillomavirus (HPV) Vaccination: Progress, Challenges, and Future Directions in Global Immunization Strategies

Branda, F., Pavia, G., Ciccozzi, A., Quirino, A., Marascio, N., Gigliotti, S., Matera, G., Romano, C., Locci, C., Azzena, I., et al. (2024) · Vaccines · doi:10.3390/vaccines12111293 · Cited by 37

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia

Simms, K. T., Hall, M. T., Smith, M. A., Lew, J., Hughes, S., Yuill, S., Hammond, I. G., Saville, M., & Canfell, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0163509 · Cited by 37

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework

Xu, L., Padalko, E. Y., Oštrbenk, A., Poljak, M., & Arbyn, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092704 · Cited by 37

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework

Bonde, J. H., Pedersen, H., Quint, W., Xu, L., Arbyn, M., & Ejegod, D. M. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01518-19 · Cited by 37

Cervical Cancer Screening with HPV Testing: Updates on the Recommendation

Carvalho, C. F., Teixeira, J. C., Bragança, J. F., Derchain, S., Zeferino, L. C., & Vale, D. B. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1739314 · Cited by 36

An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation

Okunade, K. S., Adejimi, A. A., John‐Olabode, S., Oshodi, Y. A., & Oluwole, A. A. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s296914 · Cited by 36

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

Wang, J., Elfström, K. M., Lagheden, C., Eklund, C., Sundström, K., Sparén, P., & Dillner, J. (2023) · PLoS Medicine · doi:10.1371/journal.pmed.1004304 · Cited by 36

Capillarity-powered and CRISPR/Cas12a-responsive DNA hydrogel distance sensor for highly sensitive visual detection of HPV DNA

Pian, H., Wang, H., Wang, H., Tang, F., & Li, Z. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116657 · Cited by 36

HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial

Tranberg, M., Bech, B. H., Blaakær, J., Jensen, J. S., Svanholm, H., & Andersen, B. S. (2018) · Clinical Epidemiology · doi:10.2147/clep.s164826 · Cited by 36

Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis

Tatar, O., Thompson, E. L., AliSher, A. N., Perez, S., Shapiro, G. K., Wade, K., Zimet, G. D., Gîlca, V., Janda, M., Kahn, J. A., et al. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.08.034 · Cited by 40

Identification of Candidate Plasma Protein Biomarkers for Cervical Cancer Using the Multiplex Proximity Extension Assay

Berggrund, M., Enroth, S., Lundberg, M., Assarsson, E., Stålberg, K., Lindquist, D., Hallmans, G., Grankvist, K., Olovsson, M. H., & Gyllensten, U. B. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001208 · Cited by 38

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

Bonde, J. H., Bottari, F., Parvu, V., Pedersen, H., Yanson, K. A., Iacobone, A. D., Kodsi, S., Landoni, F., Vaughan, L. M., Ejegod, D. M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32291 · Cited by 36

Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study

Αγοραστός, Θ., Chatzistamatiou, Κ., Tsertanidou, A., Mouchtaropoulou, E., Pasentsis, K., Kitsou, A., Moysiadis, T., Moschaki, V., Skenderi, A., Katsiki, E., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0192 · Cited by 36

Benefits and potential harms of human papillomavirus (HPV)‐based cervical cancer screening: A real‐world comparison of HPV testing versus cytology

Thomsen, L. T., Kjær, S. K., Munk, C., Ørnskov, D., & Waldstrøm, M. (2021) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.14121 · Cited by 36

The Implementation of a Primary HPV Self-Testing Cervical Screening Program in Malaysia through Program ROSE-Lessons Learnt and Moving Forward

Woo, Y. L., Khoo, S. P., Gravitt, P., Hawkes, D., Rajasuriar, R., & Saville, M. (2022) · Current Oncology · doi:10.3390/curroncol29100579 · Cited by 35

Avian and simian malaria: do they have a cancer connection?

Ward, M., & Benelli, G. (2016) · Parasitology Research · doi:10.1007/s00436-016-5352-3 · Cited by 35

Widening the offer of human papillomavirus self‐sampling to all women eligible for cervical screening: Make haste slowly

Rebolj, M., Sargent, A., Njor, S. H., & Cuschieri, K. S. (2022) · International Journal of Cancer · doi:10.1002/ijc.34358 · Cited by 35

Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 Years

Stoler, M. H., Austin, R. M., & Zhao, C. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01087-15 · Cited by 36

Guía de cribado del cáncer de cuello de útero en España, 2014

Torné, A., Saladrigues, M. D. P., Cusidó, M., Alameda, F., Ortiz, D. A., Piqué, X. C., Bordoy, J. C., Carreño, R. G., Troyas, R. M. G., Lloveras, B., et al. (2014) · Revista Española de Patología · doi:10.1016/s1699-8855(14)70203-x · Cited by 36

Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program

Loopik, D. L., Koenjer, L. M., Siebers, A. G., Melchers, W. J. G., & Bekkers, R. L. M. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.026 · Cited by 35

Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework

Oštrbenk, A., Xu, L., Arbyn, M., & Poljak, M. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01176-18 · Cited by 34

Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic

Elfström, M. K., Gray, P. G., & Dillner, J. (2023) · eLife · doi:10.7554/elife.80905 · Cited by 34

Beating Cancer Inequalities in the EU

OECD (2024) · OECD health policy studies · doi:10.1787/14fdc89a-en · Cited by 38

The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia—A Review

Kazlauskaitė, J., Žukienė, G., Rudaitis, V., & Bartkevičienė, D. (2025) · Medicina · doi:10.3390/medicina61050847 · Cited by 35

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis

Onuki, M., Matsumoto, K., Sakurai, M., Ochi, H., Minaguchi, T., Satoh, T., & Yoshikawa, H. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2016.27.e3 · Cited by 34

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

Preisler, S., Rebolj, M., Ejegod, D. M., Lynge, E., Rygaard, C., & Bonde, J. H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2518-4 · Cited by 34

Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China

Xu, H., Lin, A., Shao, X., Shi, W., Zhang, Y., & Yan, W. (2016) · Oncotarget · doi:10.18632/oncotarget.11959 · Cited by 34

Cancer screening: health impact, prevalence, correlates, and interventions

Sarma, E. A., Silver, M. I., Kobrin, S. C., Marcus, P. M., & Ferrer, R. A. (2019) · Psychology and Health · doi:10.1080/08870446.2019.1584673 · Cited by 34

Effective methylation triage of HPV positive women with abnormal cytology in a middle‐income country

Ramírez, A. T., Sánchez, G. I., Nedjai, B., Agudelo, M. C., Brentnall, A. R., Cuschieri, K. S., Castañeda, K. M., Cuzick, J. M., Lorincz, A. T., & ASC‐US‐COL Trial Group (2020) · International Journal of Cancer · doi:10.1002/ijc.33314 · Cited by 34

Prevention and Screening of HPV Malignancies

Dahlstrom, K. R., Day, A. T., & Sturgis, E. M. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2021.02.011 · Cited by 35

Updated evidence-based recommendations for cervical cancer screening in France

Hamers, F. F., Poullié, A.-I., & Arbyn, M. (2021) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000701 · Cited by 36

Triage performance and predictive value of the human gene methylation panel among women positive on self‐collected HPV test: Results from a prospective cohort study

Zhang, L., Zhao, X., Hu, S., Chen, S., Zhao, S., Dong, L., Carvalho, A. L., Muwonge, R., Zhao, F., & Basu, P. S. (2022) · International Journal of Cancer · doi:10.1002/ijc.34041 · Cited by 34

Cancer of the cervix: Early detection and cost‐effective solutions

Denny, L., & Prendiville, W. J. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.02.009 · Cited by 35

Use of HPV testing for cervical screening in vaccinated women—Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study

Bhatia, R., Kavanagh, K., Cubie, H., Serrano, I., Wennington, H., Hopkins, M. J., Pan, J., Pollock, K. G. J., Palmer, T. J., & Cuschieri, K. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30030 · Cited by 34

HPV‐mRNA and HPV‐DNA detection in samples taken up to seven years before severe dysplasia of cervix uteri

Forslund, O., Elfström, K. M., Lamin, H., & Dillner, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31819 · Cited by 34

Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature

Greenley, R., Bell, S., Rigby, S., Legood, R., Kirkby, V., & McKee, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1144674 · Cited by 36

The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation

Guthrie, S., Bienkowska-Gibbs, T., Manville, C. M., Pollitt, A., Kirtley, A., & Wooding, S. (2015) · Health Technology Assessment · doi:10.3310/hta19670 · Cited by 34

miR-101 Inhibits the G1-to-S Phase Transition of Cervical Cancer Cells by Targeting Fos

Liang, X., Liu, Y., Zeng, L., Yu, C., Hu, Z., Zhou, Q., & Yang, Z. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000187 · Cited by 33

Cervical cancer prevention and screening: the role of human papillomavirus testing

Aref‐Adib, M., & Freeman‐Wang, T. (2016) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12279 · Cited by 37

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel

Polman, N. J., Oštrbenk, A., Xu, L., Snijders, P. J. F., Meijer, C. J. L. M., Poljak, M., Heideman, D. A. M., & Arbyn, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01282-17 · Cited by 33

Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey

Gültekin, M., Karaca, M. Z., Küçükyıldız, İ. A., Dundar, S., Keskinkılıç, B., & Turkyilmaz, M. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.03.002 · Cited by 35

Cervical cancer prognosis using genetic algorithm and adaptive boosting approach

Sharma, M. (2019) · Health and Technology · doi:10.1007/s12553-019-00375-8 · Cited by 34

Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program

Sahlgren, H., Elfström, K. M., Lamin, H., Carlsten‐Thor, A., Eklund, C., Dillner, J., & Elfgren, K. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.09.039 · Cited by 33

Major clinical research advances in gynecologic cancer in 2014

Suh, D. H., Lee, K.-H., Kim, K., Kang, S., & Kim, J. (2015) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2015.26.2.156 · Cited by 33

Distribution of Human Papillomavirus (HPV) Genotypes in HIV-Negative and HIV-Positive Women with Cervical Intraepithelial Lesions in the Eastern Cape Province, South Africa

Taku, O., Mbulawa, Z. Z. A., Phohlo, K., Garcia-Jardon, M., Businge, C. B., & Williamson, A. (2021) · Viruses · doi:10.3390/v13020280 · Cited by 35

Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence

Carozzi, F., Marco, L. D., Gillio‐Tos, A., Mistro, A. D., Girlando, S., Baboçi, L., Trevisan, M., Burroni, E., Grasso, S., Rossi, P. G., et al. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.04.009 · Cited by 33

Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening

Castillo, M., Astudillo, A., Clavero, O., Velasco, J., Ibáñez, R., & de Sanjosé, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161403 · Cited by 33

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study

Rozemeijer, K., Naber, S. K., Penning, C., Overbeek, L. I. H., Looman, C. W. N., de Kok, I. M. C. M., Matthijsse, S. M., Rebolj, M., van Kemenade, F. J., & van Ballegooijen, M. (2017) · BMJ · doi:10.1136/bmj.j504 · Cited by 33

Role of HPV DNA testing in modern gynaecological practice

Ronco, G., & Rossi, P. G. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.002 · Cited by 33

Update on primary HPV screening for cervical cancer prevention

Rizzo, A. E., & Feldman, S. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.06.013 · Cited by 33

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence

Arbyn, M., Rezhake, R., Yuill, S., & Canfell, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0787-9 · Cited by 35

Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening

Chatzistamatiou, Κ., Moysiadis, T., Moschaki, V., Panteleris, N., & Αγοραστός, Θ. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.04.027 · Cited by 32

LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia

Barchitta, M., Quattrocchi, A., Maugeri, A., Cantó, C. O., Rosa, N. L., Cantarella, M. A., Spampinato, G., Scalisi, A., & Agodi, A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3582-0 · Cited by 32

Emerging biomarkers and clinical significance of HPV genotyping in prevention and management of cervical cancer

Shah, U. J., Nasiruddin, M., Dar, S. A., Khan, M. K. A., Akhter, M. R., Singh, N., Rabaan, A. A., & Haque, S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104131 · Cited by 32

Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan

Onuki, M., Matsumoto, K., Iwata, T., Yamamoto, K., Aoki, Y., Maenohara, S., Tsuda, N., Kamiura, S., Takehara, K., Horie, K., et al. (2020) · Cancer Science · doi:10.1111/cas.14445 · Cited by 33

Vaginal Microbiome-Based Bacterial Signatures for Predicting the Severity of Cervical Intraepithelial Neoplasia

Lee, Y. H., Kang, G.-U., Jeon, S. Y., Tagele, S. B., Pham, H. Q., Kim, M.-S., Ahmad, S., Jung, D.-R., Park, Y.-J., Han, H. S., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10121013 · Cited by 32

A novel cuproptosis-related gene signature for predicting prognosis in cervical cancer

Lei, L., Tan, L., & Sui, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.957744 · Cited by 32

Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

Uijterwaal, M. H., Polman, N. J., van Kemenade, F. J., Haselkamp, S. V. D., Lissenberg-Witte, B. I., Rijkaart, D., Berkhof, J. H., Snijders, P. J. F., & Meijer, C. J. L. M. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0409 · Cited by 33

Factors Associated with Unsatisfactory Pap Tests Among Sexually Active Trans Masculine Adults

Wang, J. C., Peitzmeier, S. M., Reisner, S. L., Deutsch, M. B., Potter, J. E., Pardee, D. J., & Hughto, J. M. W. (2023) · LGBT Health · doi:10.1089/lgbt.2021.0400 · Cited by 31

Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening

Arbyn, M., Cuschieri, K. S., Bonde, J. H., Schuurman, R., Cocuzza, C. E., Broeck, D. V., Zhao, F., Rezhake, R., Gültekin, M., de Sanjosé, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29881 · Cited by 31

Cervical intraepithelial neoplasia: screening and management

Mitra, A., Tzafetas, M., Lyons, D., Fotopoulou, C., Paraskevaidis, E., & Kyrgiou, M. (2016) · British Journal of Hospital Medicine · doi:10.12968/hmed.2016.77.8.c118 · Cited by 31

Early detection and prevention

Dillner, J. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12459 · Cited by 31

Bioinformatics prediction and analysis of hub genes and pathways of three types of gynecological cancer

Liu, Y., Yi, Y., Wu, W., Wu, K., & Zhang, W. (2019) · Oncology Letters · doi:10.3892/ol.2019.10371 · Cited by 31

Adherence to triage among women with HPV-positive self-collection: a study in a middle-low income population in Argentina

Paolino, M., Gago, J. E., Pera, A. L., Cinto, O., Thouyaret, L., & Arrossi, S. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1138 · Cited by 34

He Tapu Te Whare Tangata (sacred house of humanity): Under‐screened Māori women talk about HPV self‐testing cervical screening clinical pathways

Adcock, A., Stevenson, K., Cram, F., MacDonald, E. J., GELLER, S. E., Hermens, J., & LAWTON, B. A. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13873 · Cited by 31

CoCoss-Trial: Concurrent Comparison of Self-Sampling Devices for HPV-Detection

Ertik, F. C., Kampers, J., Hülse, F., Stolte, C., Böhmer, G., Hillemanns, P., & Jentschke, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph181910388 · Cited by 31

Efficacy of HPV-Based Screening for Prevention of Invasive Cervical Cancer

Ronco, G., Dillner, J., Elfström, K. M., Tùnesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H. C., Segnan, N., Gilham, C., Rossi, P. G., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000453824.69728.c0 · Cited by 6

Embracing a new era in cervical cancer screening

Isidean, S. D., & Franco, E. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62028-0 · Cited by 18

Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden

Wang, J., Elfström, K. M., & Dillner, J. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00218-4 · Cited by 63

Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden

Yao, Q. Y., Wang, J., Elfström, M. K., Strander, B., Dillner, J., & Sundström, K. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004505 · Cited by 6

HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis

Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f6624